Cellid, Co., Ltd. (KOSDAQ:299660)
2,390.00
-100.00 (-4.02%)
Jun 10, 2026, 3:30 PM KST
Cellid, Market Cap
Cellid, has a market cap or net worth of 70.51 billion as of June 10, 2026. Its market cap has decreased by -0.70% in one year.
Market Cap
70.51B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2,390.00
Market Cap Chart
Since February 20, 2019, Cellid,'s market cap has decreased from 482.44B to 70.51B, a decrease of -85.38%. That is a compound annual growth rate of -23.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 70.51B | -16.43% |
| Dec 30, 2025 | 84.38B | -20.98% |
| Dec 30, 2024 | 106.78B | 75.61% |
| Dec 28, 2023 | 60.81B | -46.82% |
| Dec 29, 2022 | 114.34B | -76.07% |
| Dec 30, 2021 | 477.80B | 21.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 60.09T |
| Celltrion | 36.82T |
| ALTEOGEN | 17.49T |
| Samsung Epis Holdings | 10.43T |
| Sugentech | 74.38B |
| Ray Co., Ltd. | 73.51B |
| PharmGen Science | 70.32B |
| P&S Robotics | 69.43B |